Colorectal Cancer Clinical Trials in New York

Showing 381-381 of 381 trials

A Trial of ALIMTA (Pemetrexed) Plus Irinotecan in Patients Who Have Been Previously Treated For Metastatic Colorectal Cancer.

NCT00034502

This is a non-randomized study in patients who have received prior 5-FU therapy for colorectal cancer. The objective of this trial is to establish a maximum tolerated dose of ALIMTA and irinotecan given in combination as well as to assess the safety and efficacy of this combination for patients with locally advanced or metastatic colorectal cancer. ALIMTA and irinotecan will be given every 21 days.

Colorectal Cancer

Eli Lilly and Company

Wichita, Kansas, United States • New York, New York, United States • Pittsburgh, Pennsylvania, United States +6 more locations

A Trial of ALIMTA (Pemetrexed) Plus Irinotecan in Patients Who Have Been Previously Treated For Metastatic Colorectal Cancer.

Colorectal Cancer Trials in Other Cities

Other Conditions in New York